Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II

Front Immunol. 2023 Jul 3:14:1222675. doi: 10.3389/fimmu.2023.1222675. eCollection 2023.

Yueyi Li¹, Yusha Wang¹, Jinsheng Gao^{1

2}, Keqin Tan¹, Benjamin Frey³, Udo S Gaipl³, Hubing Shi^{1

4}, Xuelei Ma¹

¹ Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
² People's Hospital of Yilong County, Nanchong, Sichuan, China.
³ Translational Radiobiology, Universitätsklinikum Erlangen, Erlangen, Germany.
⁴ Laboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China.

No abstract available

Keywords: colorectal cancer; editorial; esophageal cancer (EC); mmune checkpoint inhibitors (ICIs); non-small cell lung cancer (NSCLC).

Publication types